Advertisement
New Zealand markets closed
  • NZX 50

    12,325.60
    -3.84 (-0.03%)
     
  • NZD/USD

    0.6011
    -0.0039 (-0.64%)
     
  • NZD/EUR

    0.5519
    -0.0024 (-0.44%)
     
  • ALL ORDS

    8,209.20
    -63.50 (-0.77%)
     
  • ASX 200

    7,971.60
    -64.90 (-0.81%)
     
  • OIL

    80.25
    -2.57 (-3.10%)
     
  • GOLD

    2,402.80
    -53.60 (-2.18%)
     
  • NASDAQ

    19,522.62
    -182.47 (-0.93%)
     
  • FTSE

    8,155.72
    -49.17 (-0.60%)
     
  • Dow Jones

    40,287.53
    -377.49 (-0.93%)
     
  • DAX

    18,171.93
    -182.83 (-1.00%)
     
  • Hang Seng

    17,417.68
    -360.73 (-2.03%)
     
  • NIKKEI 225

    40,063.79
    -62.56 (-0.16%)
     
  • NZD/JPY

    94.6330
    -0.5090 (-0.53%)
     

Three High Insider Ownership Growth Companies On Euronext Paris With Up To 101% Earnings Growth

Amidst a backdrop of political uncertainty and fluctuating market conditions across Europe, France's market has particularly felt the impact, with significant movements in bond yields and equity indices. In such an environment, exploring growth companies with high insider ownership on Euronext Paris could offer investors a unique blend of potential resilience and growth, given that high insider ownership often aligns company leadership closely with shareholder interests.

Top 10 Growth Companies With High Insider Ownership In France

Name

Insider Ownership

Earnings Growth

VusionGroup (ENXTPA:VU)

13.5%

25.2%

Groupe OKwind Société anonyme (ENXTPA:ALOKW)

24.8%

30.6%

Adocia (ENXTPA:ADOC)

12.1%

104.5%

OSE Immunotherapeutics (ENXTPA:OSE)

25.6%

79.3%

Icape Holding (ENXTPA:ALICA)

30.2%

26.1%

Arcure (ENXTPA:ALCUR)

21.4%

42.4%

La Française de l'Energie (ENXTPA:FDE)

20.1%

34.2%

Munic (ENXTPA:ALMUN)

29.4%

150%

WALLIX GROUP (ENXTPA:ALLIX)

19.8%

101.6%

MedinCell (ENXTPA:MEDCL)

16.4%

74.6%

Click here to see the full list of 22 stocks from our Fast Growing Euronext Paris Companies With High Insider Ownership screener.

ADVERTISEMENT

Underneath we present a selection of stocks filtered out by our screen.

Lectra

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Lectra SA, with a market cap of €1.05 billion, offers industrial intelligence solutions across the fashion, automotive, and furniture sectors in regions including Northern Europe, Southern Europe, the Americas, and Asia Pacific.

Operations: The revenue for the company across its operational regions includes €170.33 million from the Americas and €110.28 million from the Asia Pacific.

Insider Ownership: 19.6%

Earnings Growth Forecast: 28.6% p.a.

Lectra, a French growth company with high insider ownership, shows promising financial trends despite some challenges. Its revenue is expected to grow at 11.3% annually, outpacing the broader French market's 5.8%. Additionally, earnings are projected to surge by 28.6% per year over the next three years. However, its Return on Equity is anticipated to be modest at 13.3%. Recently, Lectra reported a slight dip in net income and EPS in Q1 2024 compared to the previous year but maintained stable sales growth. Trading at 35.7% below its estimated fair value suggests potential undervaluation relative to peers.

ENXTPA:LSS Earnings and Revenue Growth as at Jun 2024
ENXTPA:LSS Earnings and Revenue Growth as at Jun 2024

MedinCell

Simply Wall St Growth Rating: ★★★★★☆

Overview: MedinCell S.A. is a French pharmaceutical company specializing in the development of long-acting injectable medications across multiple therapeutic areas, with a market capitalization of approximately €393.48 million.

Operations: The company generates its revenue primarily from the pharmaceuticals segment, totaling €11.95 million.

Insider Ownership: 16.4%

Earnings Growth Forecast: 74.6% p.a.

MedinCell S.A., a French growth company with high insider ownership, is navigating through financial challenges with promising prospects. Despite a decline in annual revenue to €11.95 million and a net loss of €25.04 million, the company's revenue growth rate stands at 42.9% per year, significantly outpacing the French market average of 5.8%. Analysts expect MedinCell to become profitable within three years and project an earnings growth rate of 74.59% annually, reflecting potential recovery and value despite current volatility and shareholder dilution concerns from the past year.

ENXTPA:MEDCL Ownership Breakdown as at Jun 2024
ENXTPA:MEDCL Ownership Breakdown as at Jun 2024

OVH Groupe

Simply Wall St Growth Rating: ★★★★☆☆

Overview: OVH Groupe S.A. offers a range of cloud services, shared hosting, and dedicated server solutions globally, with a market capitalization of approximately €0.99 billion.

Operations: The company generates revenue primarily through three segments: Public Cloud (€140.71 million), Private Cloud (€514.59 million), and Web cloud (€179.45 million).

Insider Ownership: 10.5%

Earnings Growth Forecast: 101.5% p.a.

OVH Groupe, amidst a volatile share price, is on a trajectory toward profitability within three years with its revenue growth (10.9% per year) outpacing the French market's 5.8%. Although its return on equity is expected to remain low at 3.7%, earnings are projected to surge by 101.5% annually. Recent strategic hires like Celine Choussy and Benjamin Revcolevschi underscore the company’s commitment to innovation and international expansion, aligning with OVH's strategic development goals despite current financial challenges evidenced by a reduced net loss from €26.59 million to €17.24 million in the latest half-year report.

ENXTPA:OVH Ownership Breakdown as at Jun 2024
ENXTPA:OVH Ownership Breakdown as at Jun 2024

Turning Ideas Into Actions

Want To Explore Some Alternatives?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Companies discussed in this article include ENXTPA:LSS ENXTPA:MEDCL and ENXTPA:OVH.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com